Transplantation in adults with congenital heart disease

Progress in Cardiovascular Diseases

Volumn 53, Issue 4, 2011, Pages 312-323

  McGlothlin, Dana ^a   De Marco, Teresa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult congenital heart disease; Heart transplantation; Heart lung transplantation; Lung transplantation; Transplantation

Indexed keywords

HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PANEL REACTIVE ANTIBODY; STEROID;

ACUTE GRAFT REJECTION; ADULT; ADULT CONGENITAL HEART DISEASE; AGE DISTRIBUTION; ANTIBODY SCREENING; ARTICLE; CAUSE OF DEATH; CONGENITAL HEART DISEASE; DIABETES MELLITUS; GRAFT FAILURE; GRAFT SURVIVAL; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MAINTENANCE THERAPY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK FACTOR; STEROID THERAPY; SURGICAL ANATOMY; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; DISEASE PROGRESSION; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; REOPERATION; SURVIVAL ANALYSIS; SURVIVORS; VASCULAR RESISTANCE;

EID: 79551499255     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2010.12.002     Document Type: Article

References (35)

1. Macmahon B., McKeown T., Record R.G. The incidence and life expectation of children with congenital heart disease. Br Heart J 1953, 15:121-129.
2. Warnes C.A., et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008, 118:2395-2451.
3. Thorne S., Deanfield J. Long-term outlook in treated congenital heart disease. Arch Dis Child 1996, 75:6-8.
4. Stehlik J., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report. J Heart Lung Transplant 2010, 29:1089-1103.
5. Hosseinpour A.R., Cullen S., Tsang V.T. Transplantation for adults with congenital heart disease. Eur J Cardiothorac Surg 2006, 30:508-514.
6. Warnes C.A., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1-e121.
7. Hopkins W.E., et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996, 15(1 Pt 1):100-105.
8. Christie J.D., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report. J Heart Lung Transplant 2010, 29:1104-1118.
9. Dimopoulos K., et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for PAH. Circulation 2010, 121:20-25.
10. Stoica S.C., et al. Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Ann Thorac Surg 2001, 72:1887-1891.
11. Patel N.D., et al. Heart transplantation for adults with congenital heart disease: analysis of the United Network of Organ Sharing database. Ann Thorac Surg 2009, 88:814-821. [discussion 821-2].
12. Murali S., et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993, 126:896-904.
13. Murali S., et al. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 1991, 122:1375-1381.
14. Mehra M.R., Kobashigawa J., Starling R., et al. Listing Criteria for Heart Transplantation. J Heart Lung Transplant 2006, 25:1024-1042.
15. Pigula F.A., et al. Cardiopulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant 2001, 20:297-303.
16. Waddell T.K., et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002, 21:731-737.
17. Smith J.D., et al. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995, 60(2 Suppl):S127-S130.
18. Nwakanma L.U., et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007, 84:1556-1562. [discussion 1562-3].
19. Loh E., et al. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 1994, 13:194-201.
20. Lavee J., et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1991, 10:921-929. [discussion 929-30].
21. Kobashigawa J.A., et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 1996, 94(9 Suppl):II294-II297.
22. Lamour J.M., et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation 1999, 100(19 Suppl):II200-II205.
23. Irving C, et al: Cardiac transplantation in adults with congenital heart disease. Heart 2010;96:1217-1222.
24. Karamlou T, et al: A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg 140: pp. 161-8.
25. Data come from the ISHLT International Registry for Heart and Lung Transplantation 2010 Slide Set available at http://www.ishlt.org/registries/.
26. Goerler H., et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg 2007, 32:926-931.
27. Coskun O., et al. Heart transplantation in adults with congenital heart disease: experience with 15 patients. Asaio J 2007, 53:103-106.
28. Izquierdo M.T., et al. Mortality after heart transplantation in adults with congenital heart disease: a single-center experience. Transplant Proc 2007, 39:2357-2359.
29. Young J.B., et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multi-institutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994, 13:353-364. discussion 364-5.
30. Lamour J.M., et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol 2009, 54:160-165.
31. Cohen O., et al. Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation. Transplant Proc 2007, 39:3297-3302.
32. Flattery M.P., Baker K.M. Evidence for racial disparity in cardiac transplantation survival rates. J Cult Divers 2004, 11:25-30.
33. Pamboukian S.V., et al. Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care. J Card Fail 2003, 9:80-86.
34. Radovancevic B., et al. Factors predicting 10-year survival after heart transplantation. J Heart Lung Transplant 2005, 24:156-159.
35. Kirklin J.K., et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988, 7:331-336.